LYEL
Lyell Immunopharma, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website lyell.com
- Employees(FY) 274
- ISIN US55083R1041
Performance
+2.76%
1W
-13.29%
1M
+47.04%
3M
+37.37%
6M
+34.54%
YTD
-13.29%
1Y
Profile
Lyell Immunopharma, Inc., a clinical-stage cell therapy company, engages in developing T-cell reprogramming technologies for patients with solid tumors. It develops therapies using an ex vivo genetic reprogramming technologies, such as c-Jun overexpression and NR4A3 gene knockout, to endow resistance to T-cell exhaustion; and an ex vivo epigenetic reprogramming technologies, including Epi-R to generate population of T cells with durable stemness, and Stim-R, a proprietary synthetic cell mimetic. The company's pipeline includes LYL797, a genetically and epigenetically reprogrammed ROR1 chimeric antigen receptor (CAR) T-cell product candidate for the treatment of various solid tumors; LYL845, an epigenetically reprogrammed tumor-infiltrating lymphocytes product candidate that targets multiple solid tumors; LYL119, a CAR T-cell product candidate for enhanced cytotoxicity. The company was incorporated in 2018 and is headquartered in South San Francisco, California.
Investment Analysis Report: LYEL
Overview:
LYEL is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $468,476,284. In this report, we will conduct a detailed analysis of LYEL's financial health, earnings and revenue growth, profitability, operating margin, ...
Technical Analysis of LYEL 2024-05-10
Overview:
In analyzing the technical indicators for LYEL stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and recommendations for potent...
Recent News & Updates
- 2023-10-30 21:00
- 2023-10-09 07:32
- 2023-09-26 21:00
- 2023-09-10 20:00
- 2023-08-31 04:05
- 2023-08-08 07:10
Lyell Immunopharma: Q2 Earnings Snapshot(Yahoo Finance)
- 2023-08-08 04:05
- 2023-07-11 20:47
- 2023-07-05 04:05
- 2023-06-15 22:47
Why Shares of Lyell Immunopharma Jumped This Week(Yahoo Finance)
- 2023-06-07 04:05
- 2023-05-31 19:55
- 2023-05-04 07:25
- 2023-05-04 06:25
Lyell Immunopharma: Q1 Earnings Snapshot(Yahoo Finance)
- 2023-05-04 04:05
- 2023-05-02 04:05
- 2023-04-16 19:11
- 2023-03-26 16:52
- 2023-03-25 22:14
- 2023-02-28 07:15
- 2023-02-28 03:05
- 2023-02-01 17:43
- 2023-01-03 03:05
- 2022-12-22 17:36
- 2022-12-15 21:48
- 2022-12-14 18:00
- 2022-12-08 20:35
- 2022-12-01 03:05
- 2022-11-11 18:39
- 2022-11-10 03:05